Clinical efficacy and safety of an ultrasound apparatus T-75 in the treatment of patients with ischemic heart disease
Not Applicable
Recruiting
- Conditions
- Angina pectoris
- Registration Number
- JPRN-UMIN000012369
- Lead Sponsor
- Tohoku University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients whose target area cannot be observed with echocardiography. 2) Intracardiac thrombus. 6) Less than 28 days after the last revascularization (PCI or CABG). 4) Q-wave myocardial infarction within 28 days. 5) Non-Q-wave myocardial infarction within 42 days. 6) Cardiogenic shock or worsening heart failure (to require continuous infusion of cardiovascular agents such as inotropic agents or vasodilator ). 7) Patients whose clinical condition changed after the last coronary angiography. 8) Uncontrolled diabetic retinopathy. 9) Patients who have malignant tumor or who have undergone surgery because of malignancy within the past five years.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency in use of nitrates per week.
- Secondary Outcome Measures
Name Time Method Symptom (CCS class scores, Frequency of chest pain per week). Exercise tolerance (Treadmill test, 6-minute walk test). Myocardial perfusion (Stress myocardial perfusion scintigraphy). Cardiac function (only in pts. with LVEF =< 40%).